Method for detecting sinusoidal obstruction syndrome (SOS)

摘要

Disclosed is a biomarker panel for assessing subjects at risk for early sinusoidal obstruction syndrome (SOS) after hematopoietic stem cell transplantation (HSCT). Specifically, this disclosure relates to the use of one or more of ST2, ANG2, L-ficolin, HA, and VCAM1 for prognosticating, diagnosing, and / or treating SOS. [Selection figure] None